Sponsored Links

 

Displaying avastin PowerPoint Presentations



Bevacizumab: Hallmark Drug in Tumor Treatment by Targeting ... PPT

Presentation Summary : Avastin (Bevacizumab) : Hallmark Anti-angiogenic Non-chemotherapeutic Drug Elizabeth Liao Terminology Bevacizumab- marketed as Avastin Non-chemotherapeutic- refers to ...

Source : http://www.science.smith.edu/departments/Biochem/Chm_357/Articles/Bevacizumab%20presentation%20Revised.ppt

PowerPoint Presentation PPT

Presentation Summary : Avastin® (bevacizumab) United States Food and Drug Administration Oncologic Drugs Advisory Committee December 5, 2007 Overview David Schenkein, MD Senior VP ...

Source : http://www.fda.gov/ohrms/dockets/ac/07/slides/2007-4332s1-03-Genentech.ppt

PowerPoint Presentation PPT

Presentation Summary : What is the role of continued anti-VEGF therapy? Mark Kozloff The University of Chicago Chicago, IL, USA Discussion question Bevacizumab precisely inhibits VEGF Given ...

Source : http://www.avastin.net/content/dam/avastin/en/webcasts/mark-kozloff/Mark%20Kozloff%20Webcast%20Slides.ppt

Clinical trials of Avastin® (bevacizumab) in colorectal ... PPT

Presentation Summary : Title: Clinical trials of Avastin® (bevacizumab) in colorectal cancer (CRC) Author: lambiasa Last modified by: standard Created Date: 12/5/2006 12:00:16 PM

Source : http://mso.cinbo.org/wp-content/uploads/2012/07/G_Vincenzo%20Adamo_Bevacizumab.ppt

Bevacizumab safety in patients with central nervous system ... PPT

Presentation Summary : Bevacizumab safety in patients with central nervous system metastases Besse B, Lasserre SF, Compton P, Huang J, Augustus S, Rohr U-P Clin Cancer Res 2010;16:269–78

Source : http://www.avastin.net/content/dam/avastin/en/prescribing-avastin/Bevacizumab_safety_in_patients_with_CNS_metastases_20110511.ppt

Understanding the mode of action of Avastin (bevacizumab) PPT

Presentation Summary : Understanding the mode of action of Avastin (bevacizumab) Introduction VEGF is the predominant regulator of tumour angiogenesis,1,2 a fundamental process required for ...

Source : http://www.roche-diagnostics.hu/fmfiles/re7279005/Attached_Files/Understanding-the-mode-of-action-of-Avastin.ppt

Bevacizumab: redefining cancer treatment PPT

Presentation Summary : Title: Bevacizumab: redefining cancer treatment Subject: master template Author: daniel_t Last modified by: Liz Beatty Created Date: 4/1/2009 3:07:34 PM

Source : http://www.avastin.ru/fmfiles/re7161003/The_role_of_VEGF_in_lung_cancer.ppt

Finger's Slotted Eye Plaque Radiation Therapy for ... PPT

Presentation Summary : Bevacizumab (Avastin) as a potential novel adjunct in the management of pterygia. Med Hypotheses. 2007;69(4):925-7. Kuo CH, Miyazaki D, Nawata N, ...

Source : http://ascrs2008.abstractsnet.com/handouts/000195_Chris_ASCRS_Avastin_Pterygium.ppt

Low Vision/Contact Lens Update - Texas Tech University Health ... PPT

Presentation Summary : Subconj Avastin injection given during follow up care after PKP for neovascularization. Pt is using Vitamin A ointment in each eye.

Source : http://www.ttuhsc.edu/som/ophthalmology/Resources/case%20presentations/cl_lowvisionupdate.ppt

Bevacizumab Nasal Spray for Frequent Epistaxis in HHT PPT

Presentation Summary : Bevacizumab (Avastin) bij ROW R.J.Snijder, longarts St AntoniusZiekenhuis Nieuwegein | Results Freq epistaxis/day Duration of epistaxis min/day Severity of epistaxis ...

Source : http://www.hartenvaatgroep.nl/uploads/media/Medicijn_Bevacizumab_R_Snijder_.ppt

Phase II Xeloda with irinotecan vs Xeloda with oxaliplatin ... PPT

Presentation Summary : Title: Phase II Xeloda with irinotecan vs Xeloda with oxaliplatin, both with Avastin in first-line MCRC (ML18405) Author: Stevenson_L Last modified by

Source : http://www.roche.com.mx/fmfiles/re775001/Redrawn_Xeloda_slides_v1d.ppt

PowerPoint Template - White Background PPT

Presentation Summary : ... (Avastin) Non-RCRA Hazardous Carmustine (Bicnu) Non-RCRA Hazardous Irinotecan Hydrochloride (Campostar) Non-RCRA Hazardous Doxorubicin Hydrochloride ...

Source : http://www.nhha.org/nhha/state_law/environment/Pharmaceutical%20Waste%20Mgt.ppt

ANTIANGIOGENESIS - Southern Methodist University PPT

Presentation Summary : ... (Avastin) Antiangiogenesis Targets Neovasculature 1. Proteases that breakdown the ECM 2. Growth factors that stimulate endothelial cell proliferation 3.

Source : http://faculty.smu.edu/jbuynak/Antiangiogenesis_LauraRoberts.ppt

Case Study - Clinicians Channel PPT

Presentation Summary : Avastin (bevacizumab). Package insert. Genentech BioOncology; 2004. 2. Skillings J, et al. ASCO; May 13-17, 2005. Abstract 3019. Bevacizumab Safety and Usage ...

Source : http://www.clinicianschannel.com/PIK/1840/1840_Slides.ppt

PowerPoint Presentation PPT

Presentation Summary : Please join Genentech BioOncology… Anti-VEGF Therapy in Metastatic Non-Small Cell Lung Cancer: Avastin (Bevacizumab) Presented by Laurie Langford Suchanek, RN, MA, AOCN

Source : http://wcminnesota.vc.ons.org/file_depot/0-10000000/10000-20000/15386/folder/93965/WCMONSmeeting11.16.10.ppt

Sponsored Links
If you find powerpoint presentation a copyright It is important to understand and respect the copyright rules of the author.
Please do not download if you find presentation copyright.
If you find a presentation that is using one of your presentation without permission, contact us immidiately at

© XPowerPoint.com